TiGenix to present at the Jefferies 2017 Global Healthcare Conference in New York

<b>Leuven (BELGIUM) – June 1, 2017, 07:00h CEST – TiGenix NV (Euronext Brussels and NASDAQ: TIG), an advanced biopharmaceutical company </b><b>focused on exploiting the anti-inflammatory properties of allogeneic, or donor-derived, stem cells to develop novel therapies for serious medical conditions</b><b>, today </b><b>announces that Eduardo Bravo, Chief Executive Officer, will be presenting at the Jefferies 2017 Healthcare Conference in New York on Wednesday, June 7 at 8:00 am EDT.</b>